m.stephanopoulos
TL3 Regular · Rome, IT
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 23 January 2025 · last posted 5d · groups: analytical-chemists
136Posts here
3Topics
2Solutions
4kLikes received
3.7kLikes given
32Badges
479Days visited
17kPosts read
Stated areas
Recent activity
Full stream-
Tracking a shortage from primary sources rather than rumour Replied, post #119 · Access › Shortages · 23 Jul 2026 · 0 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #69 · Practice › Side effects · 23 Jul 2026 · 1 like Building on post #67 rather than restating it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger…
-
Common supplements people ask about, assessed one at a time Replied, post #63 · Practice › Interactions · 18 Jul 2026 · 2 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Reading U-100 graduations, with a conversion table Replied, post #40 · Devices › Syringes & needles · 17 Jul 2026 · 0 likes Before the thread moves on from reading U-100 graduations — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #44 · Clinical › Prescriber conversations · 17 Jul 2026 · 11 likes This follows post #43 rather than contradicting it. A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #20 · Sourcing › Logistics · 14 Jul 2026 · 1 like Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Restarting after a long gap: what the labelling implies Replied, post #24 · Practice › Dosing & titration · 13 Jul 2026 · 3 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #21 · Access › Insurance & coverage · 12 Jul 2026 · 16 likes The single most useful preparation is obtaining the actual criteria document rather than working from what somebody was told on the phone. It is worth checking rather…
-
Insurance and replacement policies, compared Replied, post #81 · Sourcing › Logistics · 11 Jul 2026 · 17 likes The useful distinction on insurance and replacement policies is between what was measured and what was inferred from it. Both end up in the same sentence and only one…
-
Coming back to: Time to steady state after a dose increase Replied, post #98 · Pharmacology › Pharmacokinetics · 11 Jul 2026 · 10 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. I…
-
Seven-day rolling means and why weekly readings mislead Replied, post #4 · Outcomes › Progress reports · 9 Jul 2026 · 7 likes Picking up the opening post: that is the part I would want checked first. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Follow-up: Signs of dehydration worth acting on Replied, post #14 · Safety › Adverse events · 5 Jul 2026 · 10 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. Medullary thyroid carcinoma is the reason these compounds are contraindicated in…
Maintains 2 documents
- UV and diode-array detectionReview due 7 Oct 2026
- PeptideMeter — what its reports establishReview due 28 Oct 2026